Nicotinamide for mild to moderate ulcerative colitis
Part of Digestive system clinical trials.
This trial tests whether a special oral form of nicotinamide (a type of vitamin B3) can help control mild to moderate ulcerative colitis. The pill is designed to release the medication in the lower part of your gut, where UC often affects. Participation involves taking the study drug and having regular checkups to see how your symptoms and inflammation respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old and have mild to moderate ulcerative colitis that has lasted at least 3 months.
- You have had at least one flare-up of UC in the last year.
- You have not used any biologic drugs or strong immune-suppressing medications for UC in the past.
- You are not currently taking steroids or rectal treatments, or you are on a stable dose of 5-ASA medication for at least 4 weeks.
- You do not have severe anemia, kidney problems, or a history of colon cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational pill for people with moderate-to-severe ulcerative colitis that has not improved with standard treatments. The goal is to see if the pill can reduce symptoms like bloody stools and frequent bowel movements.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This study tests an investigational drug called IPG11406 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce symptoms and improve quality of life, and if it is safe.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
Hear when a new Ulcerative Colitis, Unspecified trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.